You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-Myeloablative Conditioning

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

Recruiting
  • Leukemia, Myeloid, Acute
  • +5 more
  • Melbourne, Victoria, Australia
    Melbourne Health
Jun 19, 2022

Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)

Active, not recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Dec 20, 2021

Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)

Recruiting
  • Kidney Transplantation
  • TCD601
  • San Francisco, California
  • +4 more
Oct 28, 2022

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

Completed
  • Severe Aplastic Anemia
  • Bone Marrow Failure Syndromes
  • Bone marrow transplant
  • +7 more
  • Baltimore, Maryland
  • +1 more
Feb 10, 2022

Kidney Transplantation Trial in United States (TCD601)

Not yet recruiting
  • Kidney Transplantation
  • TCD601
  • Chicago, Illinois
  • +4 more
Jun 13, 2022

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Single Umbilical Cord Blood Transplantation, Non-myeloablative Conditioning, Acute Lymphocytic Leukemia Trial in Minneapolis

Completed
Has Results
  • Single Umbilical Cord Blood Transplantation
  • +6 more
  • Minneapolis, Minnesota
    Novartis Investigative Site
Dec 9, 2020

Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

Completed
Has Results
  • Metastatic Melanoma
  • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
  • non-myeloablative conditioning chemotherapy
  • Los Angeles, California
    University of California Los Angeles, David Geffen School of Med
Dec 3, 2021

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

Completed
Has Results
  • Myeloproliferative Disorders
  • +3 more
  • anti-thymocyte globulin
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Oct 30, 2020

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

Not yet recruiting
  • Sickle Cell Disease
  • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

Recruiting
  • B-cell Lymphoma
  • +8 more
  • Polatuzumab vedotin
  • Valhalla, New York
    New York Medical Center
Oct 29, 2021

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

Not yet recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

Not yet recruiting
  • Lymphoid Leukemia
  • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
  • Treg CD34+ HSPC (Orca-T)
  • Palo Alto, California
    Stanford Cancer Center
Aug 17, 2022

Intravenous Busulfan And Fludarabine Myeloablative Conditioning

Completed
  • Acute Myeloid Leukemia
  • +3 more
    • (no location specified)
    Mar 16, 2022

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Fludarabine + Total Marrow Irradiation
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jun 1, 2022

    Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Stem cell infusion
    • +5 more
    • Saint Louis, Missouri
      Washington University
    Jan 17, 2023

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

    Terminated
    • Acute Myeloid Leukemia
    • +3 more
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Feb 22, 2022

    Scleroderma, Systemic Trial in Chicago (Peripheral Blood Stem Cells, Cyclophosphamide, Mesna)

    Terminated
    Has Results
    • Scleroderma, Systemic
    • Peripheral Blood Stem Cells
    • +6 more
    • Chicago, Illinois
      Northwestern University
    Jul 7, 2020

    Predict T Cell Chimerism After MSD SCT for SCD?

    Recruiting
    • Sickle Cell Disease
    • Alemtuzumab Injection [Campath]
    • Amsterdam, Netherlands
      Amsterdam Medical Centre
    Jun 20, 2023

    Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

    Recruiting
    • Myeloid Malignancies
    • fractionated busulfan-based conditioning regimen
    • Chendu, Sichuan, China
      West China Hospital, Sichuan University
    Mar 29, 2023

    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States

    Completed
    Has Results
    • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
    • +5 more
    • Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
    • GVHD prophylaxis
    • Duarte, California
    • +15 more
    Nov 2, 2021